Coronary Spasm: Clinical Features and Pathogenesis

Internal Medicine

Volumn 36, Issue 11, 1997, Pages 760-765

  Yasue, Hirofumi ^a   Kugiyama, Kiyotaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Calcium antagonists; Endothelium; Nitric oxide (NO); Variant angina

Indexed keywords

ACETYLCHOLINE; NITRIC OXIDE;

ANGIOCARDIOGRAPHY; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; CORONARY ARTERY SPASM; CORONARY BLOOD VESSEL; ELECTROCARDIOGRAPHY; HUMAN; HYPERVENTILATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ACETYLCHOLINE; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; CORONARY VESSELS; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; HUMANS; HYPERVENTILATION; NITRIC OXIDE; RISK FACTORS; VASOCONSTRICTION;

EID: 0031279259     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.760     Document Type: Article

References (59)

1. Hillis LD, Braunwald E. Coronary artery spasm. N Engl J Med 299: 695, 1978.
2. Yasue H. Pathophysiology and treatment of coronary arterial spasm. Chest 78: 216S, 1980.
3. Conti CR. Coronary artery spasm and myocardial infarction. N Engl J Med 309: 238, 1983.
4. Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circ Res 52 (Supple 1): 147, 1983.
5. Yasue H, Ogawa H, Okumura K. Coronary artery spasm in the genesis of myocardial ischemia. Am J Cardiol 63: 29E, 1989.
6. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 81: 1983, 1990.
7. Prinzmetal M, Kennamer R, Merlis R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris. Am J Med 27: 375, 1959.
8. Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S, Akiyama F. Role of autonomic nervous system in the pathogenesis of Prinzmetal' variant form of angina. Circulation 50: 534, 1974.
9. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K,Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm. Circulation 59: 938, 1979.
10. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. Am J Cardiol 43: 647, 1979.
11. Kugiyama K, Yasue H, Horio Y, et al. Effects of propranolol and nifedipine on exercise-induced attack in patients with variant angina: assessment by exercise thallium-201 myocardial scintigraphy with quantitative rotational tomography. Circulation 74: 374, 1986.
12. Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J 91: 148, 1976.
13. Bertrand M. Provocative testing for coronary artery spasm with ergometrine. in: Coronary Artery Spasm. Conti CR, Eds. Marcel Dekker, New York, 1986, p. 98.
14. Yasue H, Horio Y, Nakamura N et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 74: 955, 1986.
15. Horio Y, Yasue H, Rokutanda M, et al. Effects of intracoronary injection of acetylcholine on coronary arterial diameter. Am J Cardiol 57: 984, 1986.
16. Okumura K, Yasue H, Horio Y, et al. Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. Circulation 77: 535, 1988.
17. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H. Sensitivity and specificity of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 12: 883, 1988.
18. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 53: 557, 1983.
19. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109, 1991.
20. Yasue H, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Response of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation 81: 482, 1990.
21. Okumura K, Yasue H, Matsuyama K, et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina: hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol 27: 45, 1996.
22. Kugiyama K, Ohgusi M, Sugiyania S, et al. Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina. Am J Cardiol 79: 606, 1997.
23. Schroeder JS, Bolen JL, Quint RA. Provocation of coronary spasm with ergonovine maleate. New test with results in 57 patients undergoing coronary arteriography. Am J Cardiol 40: 487, 1977.
24. Matsuyama K, Yasue H, Okumura K, et al. Effects of H1-receptor stimulation on coronary arterial diameter and coronary hemodynamics in humans. Circulation 81: 65, 1990.
25. Okumura K, Yasue H, Matsuyuma K, Morikami Y, Ogawa H, Obata K. Effect of H1 receptor stimulation on coronary artery diameter in patients with variant angina: comparison with effect of acetylcholine. J Am Coll Cardiol 17: 338, 1991.
26. Kugiyama K, Yasue H, Okumura K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94: 266, 1996.
27. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral anteriolar tone in man. Lancet 2: 997, 1989.
28. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 88: 43, 1993.
29. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587, 1990.
30. Takemoto M, Egashira K, Usui M, et al. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99: 278, 1997.
31. Yasue H, Yoshimura M, Sugiyama S, et al. Association of a point mutation of the endothelial cell nitric oxide synthase (eNOS) gene with coronary spasm. Circulation 92: 1-363 (Suppl), 1995.
32. Yasue H, Nakayama M, Yoshimura Y, et al. The A to G mutation at nucleotide position 922 in the endothelial nitric oxide synthase gene positively associated with coronary spastic angina. Circulation 94: 1-146 (Suppl), 1996.
33. Motoyama T, Kawano H, Kugiyama K, et al. Flow-mediated, endothelium-dependent dilatation of the brachial arteries is impaired in patients with coronary spastic angina. Am Heart J 133: 263, 1997.
34. Okumura K, Yasue H, Ishizaka H, Ogawa H, Fujii H, Yoshimura M. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina. J Am Coll Cardiol 20: 838, 1992.
35. Shimokawa H, Takeshita A. Endothelium-dependent regulation of the cardiovascular system. Internal Medicine 34: 939, 1995.
36. Kugiyama K, Murohara T, Yasue H, et al. Increased constrictor response to acetylcholine of the isolated coronary arteries from patients with variant angina. Int J Cardiol 52: 223, 1995.
37. Caralis DG, Deligonul U, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation 85: 905, 1992.
38. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 87: 76, 1993.
39. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by Superoxide anion-mediated degradation of EDRF. Am J Physiol 266: H874, 1994.
40. Ohta Y, Kugiyama K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract-role of free radicals and attenuation by captopril. Atherosclerosis 131: 195, 1997.
41. Yasue H, Nagao M, Omote S, Takizawa A, Miwa K, Tanaka S. Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion. Circulation 58: 56, 1978.
42. Fujii H, Yasue H, Okumura K, et al. Hyperventilation-induced simultaneous multivessel coronary spasm in patients with variant angina: an echocardiographic and arteriographic study. J Am Coll Cardiol 12: 1184, 1988.
43. Nakao K, Ohgushi M, Yoshimura M, et al. Hyperventilation as a specific test for diagnosis of coronary artery spasm. Am J Cardiol 1997 (in press).
44. Kimura T, Yasue H, Sakaino N, Rokutanda M, Jougasaki M, Araki H. Effects of magnesium on the tone of isolated human coronary arteries: comparison with diltiazem and nitroglycerin. Circulation 79: 1118, 1989.
45. Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S. Effects of magnesium on the anginal attack induced by hyperventilation in patients with variant angina. Circulation 79: 597, 1989.
46. Kugiyama K, Yasue H, Okumura K, et al. Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina. J Am Coll Cardiol 12: 1177, 1988.
47. Goto K, Yasue H, Okumura K, et al. Magnesium deficiency detected by intravenous loading test in variant angina pectoris. Am J Cardiol 65: 709, 1990.
48. Fuster V, Badimom L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326: 242, 1992.
49. Libby P. Molecular bases of acute coronary syndromes. Circulation 91: 2844, 1995.
50. Falk E, Shah PK, Faster V. Coronary plaque disruption. Circulation 92: 657, 1995.
51. Maseri A, L'abbate A, Baroldi G, et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med 299: 1271, 1978.
52. Yasue H, Omote S, Takizawa A, Nagao M. Acute myocardial infarction induced by ergotamine tartrate: possible role of coronary arterial spasm. Angiology 32: 414, 1981.
53. Takaoka K, Yasue H, Horio Y. Possible role of coronary spasm in acute myocardial infarction precipitated by hyperventilation. Br Heart J 59: 256, 1988.
54. Oshima S, Ogawa H, Yasue H, Okumura K, Matsuyama K, Miyagi H. Increased plasma fibrinopeptide A levels during attacks induced by hyperventilation in patients with coronary spastic angina J Am Coll Cardiol 14: 150, 1989.
55. Oshima S, Yasue H, Ogawa H, Okumura K, Matsuyama K. Fibrinopeptide A is released into the coronary circulation after coronary spasm. Circulation 82: 2222, 1990.
56. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 80: 1617, 1989.
57. Masuda T, Yasue H, Ogawa H, et al. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina. Am Heart J 124: 314, 1992.
58. Masuda T, Ogawa H, Miyao Y, et al. Circadian variation in fibrinolytic activity in patients with variant angina. Br Heart J 71: 156, 1994.
59. Yasue H, Omote S, Takizawa A, et al. Comparison of coronary arteriographic findings during angina pectoris associated with ST segment elevation or depression. Am J Cardiol 47: 539, 1981.